See the DrugPatentWatch profile for Metadate
The query "Metadate er" appears incomplete and does not provide enough information for a specific answer. To generate an accurate and informative response, more context is needed.
What is Metadate?
Metadate is a brand name for a medication containing dextroamphetamine and amphetamine [1]. It is used to treat attention deficit hyperactivity disorder (ADHD) [1].
How does Metadate work?
Metadate is a central nervous system stimulant. It is believed to work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain [1]. This increase helps to improve focus, attention, and impulse control in individuals with ADHD.
What are the potential side effects of Metadate?
Common side effects of Metadate can include loss of appetite, dry mouth, trouble sleeping, weight loss, stomach pain, nausea, dizziness, and irritability [1]. More serious side effects can include cardiovascular problems, psychiatric issues, and growth suppression [1].
When does patent protection for Metadate expire?
Information regarding specific patent expiry dates for Metadate is not readily available without further specification of the drug formulation or its active ingredients. Patent information for medications can be complex and vary depending on the specific patent and any extensions or challenges. For detailed patent information, resources like DrugPatentWatch.com can be consulted [2].
Who manufactures Metadate?
Metadate is manufactured by Shire, which is now part of Takeda Pharmaceutical Company [3].